CN Patent

CN104586756A — 一种含沃替西汀的口服溶液及其制备方法

Assigned to BEIJING D-VENTUREPHARM TECHNOLOGY DEVELOPMENT Co Ltd · Expires 2015-05-06 · 11y expired

What this patent protects

本发明提供一种药物口服溶液，其含有沃替西汀及其药学上可接受的盐、水合物或多晶型物；由一种或多种选自水、水可混溶的溶剂的物质组成的适宜的药用溶剂系统、一种或多种味道增强/掩蔽剂、一种或多种防腐剂和一种或多种pH值调节剂，其中所述溶液pH值范围为3.5至4.5，以确保获得稳定的溶液。

USPTO Abstract

本发明提供一种药物口服溶液，其含有沃替西汀及其药学上可接受的盐、水合物或多晶型物；由一种或多种选自水、水可混溶的溶剂的物质组成的适宜的药用溶剂系统、一种或多种味道增强/掩蔽剂、一种或多种防腐剂和一种或多种pH值调节剂，其中所述溶液pH值范围为3.5至4.5，以确保获得稳定的溶液。

Drugs covered by this patent

vortioxetine-hydrobromide (VORTIOXETINE HYDROBROMIDE)

Patent Metadata

Patent number: CN104586756A
Jurisdiction: CN
Classification: —
Expires: 2015-05-06
Drug substance claim: No
Drug product claim: No
Assignee: BEIJING D-VENTUREPHARM TECHNOLOGY DEVELOPMENT Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.